Safety of COVID-19 vaccine in patients with myasthenia gravis: a self-controlled case series study

BackgroundThe safety of COVID-19 vaccines has been clarified in clinical trials; however, some immunocompromised patients, such as myasthenia gravis (MG) patients, are still hesitant to receive vaccines. Whether COVID-19 vaccination increases the risk of disease worsening in these patients remains u...

Full description

Bibliographic Details
Main Authors: Zhe Ruan, Xiao Huan, Yue Su, Yong-Lan Tang, Dong-Dong Meng, Da-Lin Ren, Chun-Hong Li, Si-Jia Hao, Chong-Bo Zhao, Su-Shan Luo, Zhu-Yi Li, Ting Chang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1141983/full